Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
1.570
+0.130 (9.03%)
Jul 17, 2026, 3:27 PM EDT - Market open
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $37.04 million as of July 17, 2026. Its market cap has decreased by -47.40% in one year.
Market Cap
37.04M
Enterprise Value
9.85M
1-Year Change
-47.40%
Ranking
Category
Stock Price
$1.57
ChartMarket Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $37.04M, a decrease of -82.26%. That is a compound annual growth rate of -31.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 37.04M | 6.08% |
| Dec 31, 2025 | 34.91M | -56.12% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BriaCell Therapeutics | 32.31M |
| Serina Therapeutics | 31.34M |
| Daré Bioscience | 31.01M |
| Senti Biosciences Holdings | 30.13M |
| Kyntra Bio | 29.63M |
| Plus Therapeutics | 29.46M |
| Tvardi Therapeutics | 29.08M |
| Actinium Pharmaceuticals | 28.08M |